DNA-Mediated Bioinspired MXene Gas Sensor Array with Machine Learning for Noninvasive Cancer Recognition.

Journal: ACS nano
Published Date:

Abstract

Noninvasive odor sensing is important in environmental monitoring and medical diagnosis. The two-dimensional material MXene is widely used due to its unique sensing properties but has limitations in specifically recognizing a certain gas. This study developed a bioinspired biosensor array (BBA) whose core mechanism involved programming MXene sensing interfaces through DNA base sequences to mimic molecular recognition principles of biological olfactory receptors. Integrated with machine learning algorithms, the BBA achieved preliminary identification of cancer patients by detecting exhaled gas samples from different populations. Starting from DNA molecular length, base type, and chemical modification, different DNAs were prepared and screened by orthogonal experiments to obtain five DNA/MXene composite biosensing materials with excellent sensing properties. Combined with pure MXene, a Six-channel bioinspired biosensor Array(6C-BBA) was established, and a neural network algorithm was utilized for the preliminary validation of the real odor molecules of fruits. Finally, the high-performance 6C-BBA was used to detect breath samples from stomach cancer patients, lung cancer patients, intestinal cancer patients, and healthy people, and the array showed 86.3, 94.1, 89.5, and 86.3% accuracy. This study could offer a specific method for advanced biosensor development and reveal important applications in early noninvasive recognition of diseases.

Authors

  • Shanshan Liu
    Department of Orthopaedics, Peking University Third Hospital, Beijing, China.
  • Nanlin Hu
    Department of Medical Oncology, Peking University First Hospital, Beijing, 100034, China.
  • Jiawang Hu
    Department of Chemical Engineering, Tsinghua University, Beijing, 100084, China; Key Laboratory of Industrial Biocatalysis, Ministry of Education, Tsinghua University, Beijing, 100084, China.
  • Wenting Li
    Singleron Biotechnologies, Guangzhou, China.
  • Shikai Wu
    Department of Medical Oncology, Peking University First Hospital, Beijing, 100034, China. Electronic address: skywu4923@sina.cn.
  • Xiaoyan Ma
    Department of Ultrasound, Guangdong Women and Children' Hospital, Guangzhou, P. R. China.
  • Yi-Xin Huo
    Key Laboratory of Molecular Medicine and Biotherapy, School of Life Science, Beijing Institute of Technology, BeijingĀ 100081, China.
  • Yuan Lu
    Department of Chemical Engineering, Tsinghua University, Beijing 100084, China.